Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alpha1-antitrypsin concentration in amniotic fluid.

H E Evans, L Glass, I Mandl

    Biology of the Neonate
    |January 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The inverse problem for cardiac arrhythmias.

    Chaos (Woodbury, N.Y.)·2023
    Same author

    2021 Canadian Surgery Forum: Virtual, online Sept. 21-24, 2021.

    Canadian journal of surgery. Journal canadien de chirurgie·2022
    Same author

    mTOR Inhibitor-Induced Transient Acantholytic Dermatitis.

    Journal of drugs in dermatology : JDD·2022
    Same author

    Long ECGs reveal rich and robust dynamical regimes in patients with frequent ectopy.

    Chaos (Woodbury, N.Y.)·2020
    Same author

    Retracted: Nrf2: a novel therapeutic target in fragile X syndrome is modulated by NNZ2566.

    Genes, brain, and behavior·2017
    Same author

    Uptake of selenium and mercury by captive mink: Results of a controlled feeding experiment.

    Chemosphere·2015

    Alpha1-antitrypsin levels in amniotic fluid remain stable during pregnancy. These findings suggest alpha1-antitrypsin is not a reliable indicator for predicting respiratory distress syndrome (RDS) in newborns.

    Area of Science:

    • Obstetrics and Gynecology
    • Biochemistry
    • Neonatology

    Background:

    • Alpha1-antitrypsin is a key proteinase inhibitor.
    • Its role in fetal development and respiratory health is under investigation.
    • Amniotic fluid serves as a crucial medium for fetal development.

    Purpose of the Study:

    • To quantify alpha1-antitrypsin concentrations in amniotic fluid across gestation.
    • To explore the potential correlation between amniotic fluid alpha1-antitrypsin levels and the development of respiratory distress syndrome (RDS).

    Main Methods:

    • Analysis of 80 amniotic fluid specimens collected at different gestational ages.
    • Quantification of alpha1-antitrypsin using established biochemical assays.

    Main Results:

    Related Experiment Videos

    • Median alpha1-antitrypsin concentrations showed minimal variation throughout pregnancy: 10.0 mg/100 ml (12-24 weeks), 18.7 mg/100 ml (34-37 weeks), and 16.2 mg/100 ml (>37 weeks).
    • In three cases where infants developed RDS, the median amniotic fluid alpha1-antitrypsin concentration was 12.4 mg/100 ml, showing no significant deviation.

    Conclusions:

    • Amniotic fluid alpha1-antitrypsin levels do not significantly change during pregnancy.
    • These findings indicate that amniotic fluid alpha1-antitrypsin concentration is unlikely to be a predictive marker for neonatal respiratory distress syndrome (RDS).